Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R Prentice

Showing results (31-40 of 223) with videos related to

Pageof 23
Sort By:
Nature: New Biology|January 31, 1973
Aggregation of human platelets by purified porcine and bovine antihaemophilic factorC D Forbes, C R Prentice
Haemostasis|January 1, 1976
Treatment of thrombosis by sequential therapy with ancrod followed by streptokinase. Clinical pharmacology and rheologyC D Forbes, J Barbenell, C R Prentice
Lancet (London, England)|April 6, 1974
Evidence for a qualitative defect in factor-VIII-related antigen in von Willebrand's diseaseC Thomson, C D Forbes, C R Prentice
Thrombosis Research|January 1, 1979
Resistance of ecarin thrombin to inhibition by antithrombin III: a dual role for ecarinA J Fulton, J Dempster, C R Prentice
The Southeast Asian Journal of Tropical Medicine and Public Health|January 1, 1993
Levels of plasma fibrinopeptide-A during surgery and the severity of the operationH Hariman, J A Davies, C R Prentice
Scottish Medical Journal|January 1, 1974
Proceedings: Abnormal factor 8 in Von Willebrand's diseaseC Thomson, C D Forbes, C R Prentice
British Journal of Haematology|September 1, 1974
Proceedings: Abnormal factor VIII in von Willebrand's diseaseC Thompson, C D Forbes, C R Prentice
British Journal of Haematology|May 1, 1974
Characterization of fibrin degradation products in patients on ancrod therapy: comparison with fibrinogen derivatives produced by plasminC R Prentice, W Edgar, G P McNicol
Clinical Science and Molecular Medicine|October 1, 1973
The potentiation of platelet aggregation and adhesion by heparin in vitro and in vivoC Thomson, C D Forbes, C R Prentice
Thrombosis Et Diathesis Haemorrhagica|December 31, 1973
A comparison of the effects of antihistamines on platelet functionC Thomson, C D Forbes, C R Prentice
Pageof 23

Showing results (31-40 of 223) with videos related to

Sort By:
Pageof 23
Nature: New Biology|January 31, 1973
Aggregation of human platelets by purified porcine and bovine antihaemophilic factorC D Forbes, C R Prentice
Haemostasis|January 1, 1976
Treatment of thrombosis by sequential therapy with ancrod followed by streptokinase. Clinical pharmacology and rheologyC D Forbes, J Barbenell, C R Prentice
Lancet (London, England)|April 6, 1974
Evidence for a qualitative defect in factor-VIII-related antigen in von Willebrand's diseaseC Thomson, C D Forbes, C R Prentice
Thrombosis Research|January 1, 1979
Resistance of ecarin thrombin to inhibition by antithrombin III: a dual role for ecarinA J Fulton, J Dempster, C R Prentice
The Southeast Asian Journal of Tropical Medicine and Public Health|January 1, 1993
Levels of plasma fibrinopeptide-A during surgery and the severity of the operationH Hariman, J A Davies, C R Prentice
Scottish Medical Journal|January 1, 1974
Proceedings: Abnormal factor 8 in Von Willebrand's diseaseC Thomson, C D Forbes, C R Prentice
British Journal of Haematology|September 1, 1974
Proceedings: Abnormal factor VIII in von Willebrand's diseaseC Thompson, C D Forbes, C R Prentice
British Journal of Haematology|May 1, 1974
Characterization of fibrin degradation products in patients on ancrod therapy: comparison with fibrinogen derivatives produced by plasminC R Prentice, W Edgar, G P McNicol
Clinical Science and Molecular Medicine|October 1, 1973
The potentiation of platelet aggregation and adhesion by heparin in vitro and in vivoC Thomson, C D Forbes, C R Prentice
Thrombosis Et Diathesis Haemorrhagica|December 31, 1973
A comparison of the effects of antihistamines on platelet functionC Thomson, C D Forbes, C R Prentice
Pageof 23